A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

Maze Therapeutics, Inc MAZE IPO will take place January, 31 on the NASDAQ exchange under the ticker MAZE. The company is offering shares at an expected price between $15.00 and $17.00 per share with ...

Rumors of ICE raids in the first week of Trump's presidency rattled a community that's been preparing for the his promise of ...

A small-scale homeless outreach program that Mayor Adams’ administration launched in late 2022 has proven effective. But the ...

The Indian economy's growth hinges on fostering a startup-friendly environment by reducing bureaucratic complexities. Key ...

Here are 17 date ideas in Auckland that aren’t dinner and a movie.

Metsera and Maze Therapeutics priced their Nasdaq IPOs, raising $275M and $140M respectively. Both companies backed by ARCH ...

An absolute behemoth of a track. From its dizzying opening to the groove it falls into, up to the stadium-sized chorus it hits, "Into The Storm" is a killer that Gojira really ought to play live at ...

A new trademark filing reveals that the once-dominant video rental chain is looking to reinvent itself by offering a range of entertainment and dining experiences.

PS Plus members have until February 3 to download January's selections, including Suicide Squad: Kill the Justice League, Need for Speed Hot Pursuit Remastered, and The Stanley Parable: Ultra Deluxe.

The pizza chain itself is among the buyers who won the right to buy restaurants owned by the bankrupt EYM Group for nearly ...